Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
4.860
+0.270 (5.88%)
At close: May 12, 2025, 4:00 PM
5.19
+0.33 (6.79%)
After-hours: May 12, 2025, 5:40 PM EDT
Medicus Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Medicus Pharma stock have an average target of 23.5, with a low estimate of 20 and a high estimate of 27. The average target predicts an increase of 383.54% from the current stock price of 4.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Medicus Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 → $27 | Strong Buy | Maintains | $14 → $27 | +455.56% | May 12, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $10 → $20 | Strong Buy | Maintains | $10 → $20 | +311.52% | May 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +188.07% | Apr 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +188.07% | Apr 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +188.07% | Apr 14, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -2.58 | -0.96 | -0.58 | ||
| Avg | -2.51 | -1.22 | -0.80 | ||
| Low | -2.41 | -1.34 | -0.89 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.